Activation of caspases and mitochondria in FTY720-mediated apoptosis in human T cell line Jurkat

International Immunopharmacology

Volumn 1, Issue 11, 2001, Pages 2011-2021

  Fujino, Masayuki ^a,b   Li, Xiao Kang ^a   Guo, Lei ^a   Amano, Takashi ^b   Suzuki, Seiichi ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

Apoptosis; Caspase; FTY720; Jurkat cells; Mitochondria

Indexed keywords

CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 5; CASPASE 6; CASPASE 8; CASPASE 9; CYTOCHROME C; FINGOLIMOD; INTERLEUKIN 1BETA CONVERTING ENZYME; PHOSPHATIDYLSERINE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

APOPTOSIS; CASPASES; CHROMATIN; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INDICATORS AND REAGENTS; JURKAT CELLS; MITOCHONDRIA; PROPYLENE GLYCOLS; PROTEINS; SPHINGOSINE;

EID: 0034839215     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00130-8     Document Type: Article

References (50)

1. Apoptosis and programmed cell death in immunity
2. Caspases: The executioners of apoptosis
3. Proteases to die for
4. A license to kill
5. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases
6. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
7. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c
8. Two CD95 (APO-1/Fas) signaling pathways
9. Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis
10. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
11. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
12. Cytochrome c: Can't live with it-can't live without it
13. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
14. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
15. Apoptosis, in human monocytic THP.1 cells, results in the release of cytochrome c from mitochondria prior to their ultracondensation, formation of outer membrane discontinuities and reduction in inner membrane potential
16. Design, synthesis, and structure-activity relationship of 2-substituted-2-amino-1,2-propanediols: Discovery of a novel immunosuppressant, FTY720
17. FTY720, a novel immunosuppressant possessing unique mechanisms: I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats
18. FTY720, a novel immunosuppressant possessing unique mechanisms: II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A
19. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation
20. FTY720, a novel immunosuppressant possessing unique mechanisms: III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A
21. FTY720, a novel immunosuppressant, possessing unique mechanisms: IV. Prevention of graft versus host reactions in rats
22. Induction of lymphocyte apoptosis by a novel immunosuppressant FTY720: Relation with Fas, Bcl-2 and Bax expression
23. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720
24. The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720
25. Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation
26. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway
27. Caspase requirement for the apoptotic death of WR19L-induced by FTY720
28. Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria
29. FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells
30. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes
31. An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60
32. Complement-dependent clearance of apoptotic cells by human macrophages
33. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
34. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
35. The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation
36. Mitochondrial control of apoptosis
37. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
38. Mitochondrial permeability transition is a central coordinating event of apoptosis
39. Mitochondrial control of nuclear apoptosis
40. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
41. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
42. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid
43. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
44. Mitochondria as regulators of apoptosis: Doubt no more
45. The permeability transition pore complex: A target for apoptosis regulation by caspases and bcl-2-related proteins
46. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720
47. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720
48. Immunosuppressive effect of FTY720 on rat pancreas allograft
49. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model
50. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in A caspase-9-dependent manner